ICMR, Ministry of Health & Family Welfare, Govt. of India, Govt. of Madhya Pradesh and Sun Pharma announce public-private-partnership for Malaria Free India
Sun Pharmaceutical Industries Ltd has informed BSE regarding a Press Release dated April 25, 2016 titled "ICMR, Ministry of Health & Family Welfare, Govt. of India, Govt. of Madhya Pradesh and Sun Pharma announce public-private-partnership for Malaria Free India". Shareholding for the Period Ended March 31, 2016
Sun Pharmaceutical Industries Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2016. For more details, kindly Click here Sun Pharma settles trademark litigation with Psyco Remedies
Post reaching the settlement, a joint request for compromise was filed by both companies before the Madras High Court, where they had been fighting a pitched battle Sun Pharma Laboratories, the wholly a subsidiary of Sun Pharmaceutical Industries, and Punjab-based Psyco Remedies have finally settled amicably a trademark dispute over Syzopin-an anti psychotic drug- produced [] Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015 for Quarter ended March 31, 2016
Sun Pharmaceutical Industries Ltd has informed BSE regarding Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended March 31, 2016, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Sun Pharma says sell-off plan of Irish plant final
UK trade union Unite called on Irish govt to mobilise all the state's resources to find a buyer for Sun Pharma's Ranbaxy plant Sun Pharma gets USFDA nod for eye inflammation drug
The drug has been developed by InSite Vision which the company had acquired in November 2015 Sun Pharma Receives USFDA Approval For BromSite
Sun Pharmaceutical Industries Ltd has informed BSE regarding a Press Release dated April 09, 2016 titled "Sun Pharma Receives USFDA Approval For BromSite". SPARC rights issue closes on Monday
The rights issue of Sun Pharma's subsidiary Sun Pharma Advanced Research Co (SPARC) will close on Monday. The company has plans to raise 250 crore, by issuing up to 1.02 crore equity shares for cas... Intimation of withdrawal of CARE rating at the Companys request
Sun Pharmaceutical Industries Ltd has informed BSE regarding "Intimation of withdrawal of CARE rating at the Companys request". Sun Pharma enters Japanese prescription market
Sun Pharmaceutical Industries Ltd has informed BSE regarding a Press Release dated March 29, 2016 titled "Sun Pharma enters Japanese prescription market".